Evaluating amphiregulin in plasma for metastatic colorectal cancer treated with cetuximab based therapy

ABSTRACT: Primary outcome(s): disease control rate between higher and lower amphiregulin group

DISEASE(S): Unresectable Metastatic Colorectal Cancer

PROVIDER: 2617422 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR